TransMedics Group, Inc. (TMDX) Free Cash Flow (FCF): $151.36M
The free cash flow (FCF) for TransMedics Group, Inc. (TMDX) is $151.36M. It is above its 12-month average by 474.98% ($26.32M).
TMDX Free Cash Flow (FCF) Chart
TMDX Average Free Cash Flow (FCF) Chart
TMDX Current vs Average Free Cash Flow (FCF) Chart
TMDX Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$151.36M
FREE CASH FLOW (FCF) AVG TTM
$26.32M
FREE CASH FLOW (FCF) AVG 3Y
$-49.29M
FREE CASH FLOW (FCF) AVG 5Y
$-43.38M
FREE CASH FLOW (FCF) AVG 10Y
N/A
FREE CASH FLOW (FCF) AVG 15Y
N/A
FREE CASH FLOW (FCF) AVG 20Y
N/A
CURRENT VS TTM AVG
+474.98%
CURRENT VS 3Y AVG
+407.07%
CURRENT VS 5Y AVG
+448.93%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
FCF Analysis
Free Cash Flow (TTM)
$151.36M
FCF Yield
5.31%
Price/FCF
18.8
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
TransMedics Group, Inc. Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
TransMedics Group, Inc. Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for TransMedics Group, Inc. (TMDX)?
- The free cash flow (FCF) for TMDX stock is $151.36M.
- What is the TTM average free cash flow (FCF) for TransMedics Group, Inc. (TMDX)?
- The TTM average free cash flow (FCF) for TMDX stock is $26.32M.
- What is the 3Y average free cash flow (FCF) for TransMedics Group, Inc. (TMDX)?
- The 3Y average free cash flow (FCF) for TMDX stock is $-49.29M.
- What is the 5Y average free cash flow (FCF) for TransMedics Group, Inc. (TMDX)?
- The 5Y average free cash flow (FCF) for TMDX stock is $-43.38M.
TransMedics Group, Inc. Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2025-12-31 | $133.59M |
| 2024-12-31 | $-80.94M |
| 2023-12-31 | $-192.09M |
| 2022-12-31 | $-57.72M |
| 2021-12-31 | $-32.38M |
| 2020-12-31 | $-30.72M |
| 2019-12-31 | $-32.45M |
| 2018-12-31 | $-26.40M |
| 2017-12-31 | $-23.36M |
| 2016-12-31 | $-25.59M |
Related Metrics
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Waleed H. Hassanein